About Brundavan Laboratories
Brundavan Laboratories is a Chemicals & Materials company based in Hyderabad (India) founded in 2002. It manufactures and exports bulk drugs and pharmaceutical intermediates. It operates on a B2B model in Chemicals & Materials and Healthcare sectors. The company has 68 employees. Its Indian entity Brundavan Laboratories Private Limited reported revenue of ₹84.25 Cr. Brundavan Laboratories offers products and services including Carvedilol, Fluconazole, Olanzapine, Pioglitazone Hydrochloride, and Quetiapine Fumarate. Its focus areas include Life Sciences, Chemical Manufacturing, Drug Intermediates and Synthesis and Export.
Company details
Brundavan Laboratories Pvt. Ltd., established in 2005, specializes in manufacturing and exporting bulk drugs like APIs and pharmaceutical intermediates. The company operates from Hyderabad and has a factory in Nalgonda District, Telangana, India. It employs a skilled team for research, development, and quality production under cGMP compliance, serving global pharmaceutical clients through exports and direct sales.
- Headquarters Hyderabad, India
- Employees 68
- SectorsChemicals & MaterialsHealthcare
- Email••••••••
- Website brundavanlabs.com
- Legal Name Brundavan Laboratories Private Limited
- Date of Incorporation 19 Dec, 2002
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹84.25 Cr
FY 2025 · +32% YoY
- Net Profit₹1.06 Cr
FY 2025 · 1% margin
- EBITDA₹9.09 Cr
FY 2025 · 11% margin
- Employee Count68
Associated legal entities of Brundavan Laboratories
Brundavan Laboratories operates through Brundavan Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Brundavan Laboratories Private Limited CIN U24231TG2002PTC040136 | Active | 19 Dec 2002 | Hyderabad, Telangana | ₹84.2 Cr | 68 | 4 | View details |
Products & Services of Brundavan Laboratories
Brundavan Laboratories offers a comprehensive portfolio of products and services, including Carvedilol, Fluconazole, Olanzapine, Pioglitazone Hydrochloride, and Quetiapine Fumarate.
Antihypertensive drug used for treating heart conditions.
Antifungal medication for fungal infections.
Antipsychotic drug for mental health disorders.
Medication for managing type 2 diabetes.
Antipsychotic for treating bipolar disorder.
Raw materials for synthesizing APIs.
Board of directors of Brundavan Laboratories Private Limited (Brundavan Laboratories)
Brundavan Laboratories Private Limited is the primary company behind Brundavan Laboratories. The board of Brundavan Laboratories Private Limited currently have 4 directors; the longest-serving is Kanaka Sudha Gedipudi, appointed in 2002. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kanaka Sudha Gedipudi DIN 01909433 | Director | 19 Dec 2002 | 23 yrs 10 mo | Brundavan Laboratories Private Limited |
| Vallabhaneni Rao Venkata Krishna DIN 00540523 | Director | 19 Dec 2002 | 23 yrs 10 mo | Brundavan Laboratories Private Limited |
| Ramaiah Gedipudi DIN 01828369 | Managing Director | 19 Dec 2002 | 23 yrs 10 mo | Brundavan Laboratories Private Limited |
| Venkat Sunag Gedipudi DIN 08587678 | Director | 01 Oct 2019 | 7 yrs | Brundavan Laboratories Private Limited |
Financials of Brundavan Laboratories
Figures of Brundavan Laboratories Private Limited, the primary company behind Brundavan Laboratories, for FY 2025. Revenue was ₹84.25 Cr (+32% year on year). Net profit was ₹1.06 Cr (1% margin). EBITDA was ₹9.09 Cr (11% margin). Revenue has grown at a compounded annual rate of +12% over three years and +9% over five years.
- ₹84.25 CrRevenue · FY 2025 · +32% YoY
- ₹1.06 CrNet profit · 1% margin
- ₹9.09 CrEBITDA · 11% margin
- ₹1.40 CrPaid-up capital
- 68Employees (provident fund records)
- +12%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Brundavan Laboratories Private Limited are on its company page.
Detailed financial statements for Brundavan Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Petrochemicals & Derivatives
3 companies that operate in the same segment as Brundavan Laboratories (Petrochemicals & Derivatives) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Produces and supplies specialty chemicals for energy, petrochemicals, and industrial applications worldwide. | 1992 | Mumbai, Maharashtra, India | USD 479.49 M | 976 | ||
Polybutene-based petrochemicals are produced by the company. | 1990 | Chennai, Tamil Nadu, India | USD 62.67 M | 194 | ||
Calcined petroleum coke, coal tar, and specialty chemicals are produced. | 1974 | Hyderabad, Telangana, India | USD 1.88 B | 2,390 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Brundavan Laboratories
Complete news archive for Brundavan Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brundavan Laboratories
Brundavan Laboratories was founded in 2002.
Brundavan Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Brundavan Laboratories has 68 employees.
The primary company behind Brundavan Laboratories, Brundavan Laboratories Private Limited, reported revenue of ₹84.25 Cr for FY 2025, up 32% year on year.
Brundavan Laboratories Pvt. Ltd., established in 2005, specializes in manufacturing and exporting bulk drugs like APIs and pharmaceutical intermediates. The company operates from Hyderabad and has a factory in Nalgonda District, Telangana, India. It employs a skilled team for research, development, and quality production under cGMP compliance, serving global pharmaceutical clients through exports and direct sales.
Brundavan Laboratories offers Carvedilol, Fluconazole, Olanzapine, Pioglitazone Hydrochloride, and 2 more products and services.
Brundavan Laboratories operates through Brundavan Laboratories Private Limited.
The legal entities of Brundavan Laboratories currently have 4 directors, including Venkat Sunag Gedipudi, Kanaka Sudha Gedipudi, Vallabhaneni Rao Venkata Krishna and others.